Markets:

Overview

News

Currencies

International

Treasuries

Gilead Sciences (NQ:GILD)

129.95 +3.98 (+3.16%)

Streaming Delayed Price Updated: 2:09 PM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

75 76 Next >

What the Options Market Tells Us About Gilead Sciences ↗

April 18, 2024

Via Benzinga

If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today ↗

April 17, 2024

Via Benzinga

Why the dividend investor may take a look at NASDAQ:GILD. ↗

April 17, 2024

Uncovering Dividend Opportunities with GILEAD SCIENCES INC (NASDAQ:GILD).

Via Chartmill

Better Growth Play: Merck or The Vanguard Growth Index Fund? ↗

April 15, 2024

Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?

Via The Motley Fool

Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq? ↗

April 15, 2024

Dividend stocks can be a smart way to ride out market volatility.

Via The Motley Fool

Biotech Innovations Paving the Way in Breast Cancer Fight

April 11, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,000 Today ↗

April 03, 2024

Via Benzinga

Analyzing NASDAQ:GILD's Dividend Potential. ↗

March 26, 2024

Is GILEAD SCIENCES INC (NASDAQ:GILD) a Good Fit for Dividend Investing?

Via Chartmill

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter ↗

April 11, 2024

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

3 Stocks at 52-Week Lows Poised for a Powerful Rebound ↗

April 09, 2024

Starbucks, Gilead, and Vale are three stocks at 52-week lows that show signs of recovery potential and long-term growth prospects.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 09, 2024

Via Benzinga

Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024

April 08, 2024

From Gilead Sciences, Inc.

Via Business Wire

Starbucks, Gilead And Ambev Are At 52-Week Lows: Should You Buy The Dip? ↗

April 08, 2024

Capital market investors often look for entry points, hidden gems, and value bets. Quality stocks trading at or around their 52-week low levels offer one such opportunity window.

Via Benzinga

3 No-Brainer Dividend Stocks to Buy in April ↗

April 06, 2024

Income investors will find a lot to like about these stocks.

Via The Motley Fool

Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows ↗

April 05, 2024

All of these stocks pay generous dividends that income investors will appreciate.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

April 03, 2024

Via Benzinga

Biotech Sector Nears Breakout: Will it Outperform in Q2?

April 03, 2024

The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains

Via MarketBeat

Topics ETFs

5 Healthcare Stocks to Buy for 2024 ↗

April 02, 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

Via InvestorPlace

Topics Artificial Intelligence

Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst ↗

April 01, 2024

BofA Securities downgrades Galapagos to underperform due to limited near-term catalysts and competitive challenges in crowded markets.

Via Benzinga

10 Big-Name Stocks Near 52 Week Lows: Are They A Buy? ↗

March 29, 2024

Over the past twelve months, a number of big-name companies have been near or below their 52-week low price. Each week we’ll take a look at some of the biggest names currently close to their 52-week...

Via Talk Markets

Cancer Focused Micro-Cap Xilio Therapeutics Stock Doubles In One Session - Here's Why ↗

March 28, 2024

Xilio Therapeutics soars with exclusive license pact with Gilead Sciences to advance XTX301, a Phase 1 tumor-activated IL-12 program. $43.5 million upfront, $604 million potential payments, and tiered...

Via Benzinga

Why Is Xilio Therapeutics (XLO) Stock up 168% Today? ↗

March 28, 2024

Xilio Therapeutics stock is heading higher on Thursday with heavy trading of XLO shares after announcing a deal with Gilead.

Via InvestorPlace

FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six

March 28, 2024

From Gilead Sciences, Inc.

Via Business Wire

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

March 28, 2024

From Gilead Sciences, Inc.

Via Business Wire

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

March 28, 2024

From Xilio Therapeutics, Inc.; Gilead Sciences, Inc.

Via GlobeNewswire

7 Value Stocks to Buy at a 52-Week Low in March ↗

March 28, 2024

These seven value stocks to buy all trade at low valuations, and have the potential to make big recoveries.

Via InvestorPlace

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields ↗

March 27, 2024

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich ↗

March 25, 2024

Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.

Via InvestorPlace

2 Top Dividend Stocks to Buy Hand Over Fist ↗

March 17, 2024

Every company faces headwinds eventually. The top ones know how to bounce back.

Via The Motley Fool

10 Big-Name Stocks Near 52-Week Lows: Are They A Buy? ↗

March 16, 2024

Over the past twelve months a number of big named companies have been near or below their 52 week low price. Each week we’ll take a look at some of the biggest names currently close to their 52 week...

Via Talk Markets

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

75 76 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gilead Sciences (NQ:GILD)

All News about Gilead Sciences

Starting at $3.75/week.

Subscribe Today